MedTrace Logo

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

NCT00604032 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2008-03-28

No results posted yet for this study

Summary

To assess the potential of tretnoin gel 0.05% to produce phototoxic reactions, measured as skin reactions 24 and 48 hours after UV radiation of drug on skin.

Conditions

  • Healthy

Interventions

DRUG

Atralin (tretinoin) Gel, 0.05%

Assess potential of tretinoin gel, 0.05% to produce phototoxic reactions, measured 24 and 48 hours after UV radiation of drug on the skin.

Sponsors & Collaborators

  • Coria Laboratories, Ltd.

    lead INDUSTRY

Principal Investigators

  • Joseph Stanfiled, MS · Suncare Laboratories

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-01-31
Completion
2008-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00604032 on ClinicalTrials.gov